Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)

Clinical trial NCT01254604 · COMPLETED

Trial details

NCT number: NCT01254604
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2011-12-01
Primary completion: 2013-05-09
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.